stockportfolio.pro
PTC Therapeutics, Inc. Gross Profit 2011–2025
PTC Therapeutics, Inc. (PTCT) annual gross profit by fiscal year, computed from SEC filings. Compound growth +3.2%/yr over 14 years.
| Fiscal year | Gross Profit | Gross margin | Change (YoY) |
|---|---|---|---|
| FY 2025 | — | — | — |
| FY 2024 | — | — | — |
| FY 2023 | — | — | — |
| FY 2022 | — | — | — |
| FY 2021 | — | — | — |
| FY 2020 | — | — | — |
| FY 2019 | $294.85M | 96.0% | +17.0% |
| FY 2018 | $252.06M | 95.2% | +32.8% |
| FY 2017 | $189.81M | 97.6% | — |
| FY 2016 | — | — | — |
| FY 2015 | — | — | — |
| FY 2014 | — | — | — |
| FY 2013 | — | — | — |
| FY 2012 | — | — | — |
| FY 2011 | — | — | — |
Source: PTC Therapeutics, Inc. SEC filings — income statement (10-K). Refreshed nightly.
See the full picture for PTC Therapeutics, Inc.
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freePTC Therapeutics, Inc. — frequently asked questions
What is PTC Therapeutics, Inc.'s gross profit?
PTC Therapeutics, Inc. (PTCT) reported gross profit of $294.85M for fiscal year 2019, per its SEC filings.
How has PTC Therapeutics, Inc.'s gross profit changed over time?
Between fiscal 2011 and 2025, PTCT's gross profit grew at roughly 3.2% per year (compound annual rate), from $189.81M to $294.85M.
Where does this data come from?
Figures are computed from PTC Therapeutics, Inc.'s official SEC filings (income statement (10-K)), refreshed nightly. Not investment advice.